Edison November 2013
"The annual number of hematopoietic stem cell transplants (HSCTS) in Japan is c 3,500, of which a substantial proportion are likely to be autologous HSCTS at risk of subsequent aGvHD"
Madamanswer can you help me with the maths here:
Lets say $175,000 per patient (mid 150-240) est 3500 patients pa est royalty 15%
175,000 X 3500 X 15% = A very big number I would say.
But I will let Madamanswer check my calcs first
Ann: MSB's Japan Licensee Receives Pricing For TEMCELL, page-12
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 274918 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 974 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |